Publicacións nas que colabora con José Luis Vila Jato (12)

1990

  1. Prediction of tablet properties by compression force-time profile parameters

    Drug Development and Industrial Pharmacy, Vol. 16, Núm. 2, pp. 231-241

  2. The effect of maximum compression force and drug content on compression force-time cprofile parameters

    Drug Development and Industrial Pharmacy, Vol. 16, Núm. 2, pp. 243-254

1989

  1. Technological factors and release in matricial systems. I . Plastic matrixes

    Ciencia e Industria Farmaceutica, Vol. 8, Núm. 7-9, pp. 184-190

  2. Use of the crushing strength parameter for quality control of phenobarbital-microcrystalline cellulose tablets

    Farmaco, Vol. 44, Núm. 7-8, pp. 731-737

1988

  1. Effect of compression force on biopharmaceutical characteristics of Eudragit RS-based cephalexin tablets

    International Journal of Pharmaceutics, Vol. 47, Núm. 1-3, pp. 37-42

1987

  1. Effect of different factors on stability of ceftriaxone in solution

    Farmaco, Edizione Pratica, Vol. 42, Núm. 5, pp. 131-137

  2. El diseño experimental en biofarmacia

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 3, pp. 37-43

  3. The use of compression force to control the quality of directly compressed phenobarbital formulations

    Drug Development and Industrial Pharmacy, Vol. 13, Núm. 14, pp. 2519-2527

1986

  1. Controlled release of cephalexin from double-layer tablets containing small proportions of acrylic resins

    International Journal of Pharmaceutics, Vol. 32, Núm. 2-3, pp. 99-102

1985

  1. Simplification of the Loo-Riegelman method: Generalization to non-linear kinetics

    Archivos de Farmacologia y Toxicologia, Vol. 11, Núm. 2, pp. 127-133

1984

  1. EFECTO DE LA FUERZA DE COMPRESION Y NIVEL DE AGLUTINANTE SOBRE LAS CARACTERISTICAS GALENICAS DE COMPRIMIDOS DE SULFADIAZINA

    Ciencia e Industria Farmaceutica, Vol. 3, Núm. 2, pp. 46-49

  2. EUDRAGIT E COMO EXCIPIENTE BASE DE COMPRIMIDOS DE PARACETAMOL: ESTUDIO BIOFARMACEUTICO

    Ciencia e Industria Farmaceutica, Vol. 3, Núm. 11, pp. 309-312